Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark R Gilbert

Showing results (271-280 of 453) with videos related to

Pageof 46
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 17, 2023
Protein Kinase B (PKB/AKT) Protects IDH-Mutated Glioma from Ferroptosis via Nrf2Yang Liu, Fu-Ju Chou, Fengchao Lang, et al.
Biorxiv : the Preprint Server for Biology|February 15, 2023
"Tumor Treating Fields" delivered via electromagnetic induction have varied effects across glioma cell lines and electric field amplitudesRea Ravin, Teddy X Cai, Aiguo Li, et al.
American Journal of Cancer Research|March 8, 2024
"Tumor Treating Fields" delivered via electromagnetic induction have varied effects across glioma cell lines and electric field amplitudesRea Ravin, Teddy X Cai, Aiguo Li, et al.
Future Oncology (London, England)|April 10, 2020
Temozolomide in secondary prevention of HER2-positive breast cancer brain metastasesAlexandra S Zimmer, Seth M Steinberg, Dee Dee Smart, et al.
Carcinogenesis|July 9, 2010
Gamma-radiation sensitivity and polymorphisms in RAD51L1 modulate glioma riskYanhong Liu, Sanjay Shete, Li-E Wang, et al.
Neuro-Oncology|August 24, 2010
A phase I factorial design study of dose-dense temozolomide alone and in combination with thalidomide, isotretinoin, and/or celecoxib as postchemoradiation adjuvant therapy for newly diagnosed glioblastomaMark R Gilbert, Javier Gonzalez, Kathy Hunter, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 15, 2016
Reply to F. Felix et al and M.F. Fay et alCaroline Happold, Thierry Gorlia, Oliver Chinot, et al.
Journal for Immunotherapy of Cancer|June 13, 2018
Dexamethasone-induced immunosuppression: mechanisms and implications for immunotherapyAmber J Giles, Marsha-Kay N D Hutchinson, Heather M Sonnemann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 21, 2016
Does Valproic Acid or Levetiracetam Improve Survival in Glioblastoma? A Pooled Analysis of Prospective Clinical Trials in Newly Diagnosed GlioblastomaCaroline Happold, Thierry Gorlia, Olivier Chinot, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 2006
Survival prediction in patients with glioblastoma multiforme by human telomerase genetic variationLuo Wang, Qingyi Wei, Li-E Wang, et al.
Pageof 46

Showing results (271-280 of 453) with videos related to

Sort By:
Pageof 46
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 17, 2023
Protein Kinase B (PKB/AKT) Protects IDH-Mutated Glioma from Ferroptosis via Nrf2Yang Liu, Fu-Ju Chou, Fengchao Lang, et al.
Biorxiv : the Preprint Server for Biology|February 15, 2023
"Tumor Treating Fields" delivered via electromagnetic induction have varied effects across glioma cell lines and electric field amplitudesRea Ravin, Teddy X Cai, Aiguo Li, et al.
American Journal of Cancer Research|March 8, 2024
"Tumor Treating Fields" delivered via electromagnetic induction have varied effects across glioma cell lines and electric field amplitudesRea Ravin, Teddy X Cai, Aiguo Li, et al.
Future Oncology (London, England)|April 10, 2020
Temozolomide in secondary prevention of HER2-positive breast cancer brain metastasesAlexandra S Zimmer, Seth M Steinberg, Dee Dee Smart, et al.
Carcinogenesis|July 9, 2010
Gamma-radiation sensitivity and polymorphisms in RAD51L1 modulate glioma riskYanhong Liu, Sanjay Shete, Li-E Wang, et al.
Neuro-Oncology|August 24, 2010
A phase I factorial design study of dose-dense temozolomide alone and in combination with thalidomide, isotretinoin, and/or celecoxib as postchemoradiation adjuvant therapy for newly diagnosed glioblastomaMark R Gilbert, Javier Gonzalez, Kathy Hunter, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 15, 2016
Reply to F. Felix et al and M.F. Fay et alCaroline Happold, Thierry Gorlia, Oliver Chinot, et al.
Journal for Immunotherapy of Cancer|June 13, 2018
Dexamethasone-induced immunosuppression: mechanisms and implications for immunotherapyAmber J Giles, Marsha-Kay N D Hutchinson, Heather M Sonnemann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 21, 2016
Does Valproic Acid or Levetiracetam Improve Survival in Glioblastoma? A Pooled Analysis of Prospective Clinical Trials in Newly Diagnosed GlioblastomaCaroline Happold, Thierry Gorlia, Olivier Chinot, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 2006
Survival prediction in patients with glioblastoma multiforme by human telomerase genetic variationLuo Wang, Qingyi Wei, Li-E Wang, et al.
Pageof 46